We are dedicated to our collaborators and loyal to our inventors, being flexible and creative in order to form strong alliances. We firmly believe that early engagement with industry is the key to advancing scientific innovations while accelerating drug development to bring impactful new medicines and diagnostics to people in need.
The Wistar Institute and IMV Announce Research Collaboration to Develop New Targeted Immunotherapy Against the Common BRAF Cancer Mutation
Learn more about our latest collaborations.
The Wistar Institue